Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)

NCT00961207 is registered in ClinicalTrials.gov with Cook County Health as lead sponsor.

NCT NCT00961207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00961207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Lead sponsor
Cook County Health
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2009
Completion date
September 30, 2012
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, diabetes, macroalbuminuric diabetic nephropathy, microalbuminuria, proteinuria